CATALOGO DEI PRODOTTI DELLA RICERCA

SARTORIS, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.896
EU - Europa 2.801
AS - Asia 1.316
SA - Sud America 21
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 7.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.880
GB - Regno Unito 1.163
CN - Cina 820
SG - Singapore 343
IT - Italia 266
DE - Germania 241
SE - Svezia 219
FR - Francia 200
RU - Federazione Russa 195
IE - Irlanda 190
FI - Finlandia 176
UA - Ucraina 71
VN - Vietnam 45
BE - Belgio 26
ID - Indonesia 17
TR - Turchia 16
BR - Brasile 14
JP - Giappone 12
NL - Olanda 12
KR - Corea 10
CA - Canada 9
HK - Hong Kong 8
IR - Iran 8
PL - Polonia 8
IL - Israele 7
IN - India 7
ES - Italia 6
PK - Pakistan 6
AU - Australia 5
CH - Svizzera 4
EU - Europa 4
LU - Lussemburgo 4
PA - Panama 4
AT - Austria 3
CL - Cile 3
EG - Egitto 3
KG - Kirghizistan 3
KZ - Kazakistan 3
TG - Togo 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
LT - Lituania 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
SI - Slovenia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SC - Seychelles 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 7.055
Salva come PNG Salva come JPEG
Città #
Southend 1.058
Jacksonville 518
Chandler 454
Woodbridge 387
Singapore 280
Ann Arbor 247
Dublin 185
Ashburn 177
Verona 167
Beijing 124
Houston 114
Nanjing 82
Jinan 81
Wilmington 78
Lawrence 75
Princeton 75
Shenyang 72
New York 70
Helsinki 51
Hebei 46
Haikou 41
Zhengzhou 38
Tianjin 35
Nanchang 33
Changsha 27
Dong Ket 27
Brussels 26
Sindelfingen 26
Boardman 24
Hangzhou 24
Ningbo 24
Munich 23
Redmond 23
Los Angeles 22
Taiyuan 22
Redwood City 21
Taizhou 20
Jakarta 16
Guangzhou 15
Düsseldorf 14
Santa Clara 14
Dallas 13
Nürnberg 13
Seattle 13
Jiaxing 12
Lancaster 12
Cambridge 11
Falls Church 11
Lanzhou 11
Milan 11
Moscow 11
Fairfield 10
Fuzhou 10
Seoul 10
Norwalk 9
Dearborn 8
Hong Kong 8
Kent 8
Amsterdam 7
Auburn Hills 7
Chicago 7
Philadelphia 6
Detroit 5
Isola della Scala 5
Toronto 5
Dongguan 4
Kyoto 4
Sialkot 4
Tokyo 4
Tombolo 4
Zanjan 4
Almaty 3
Bishkek 3
Kostomloty Drugie 3
Lappeenranta 3
Lomé 3
London 3
Luxembourg 3
Madrid 3
Melbourne 3
Monmouth Junction 3
Ottawa 3
Paris 3
San Diego 3
San Francisco 3
San Jose 3
San Mateo 3
Vienna 3
Washington 3
Brno 2
Buttapietra 2
Catania 2
Cerea 2
Chengdu 2
Clearwater 2
Dhaka 2
Evanston 2
Frankfurt am Main 2
Ljubljana 2
Mit Ghamr 2
Totale 5.179
Salva come PNG Salva come JPEG
Nome #
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 195
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 186
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer. 172
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 170
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 158
Cell contact-dependent PMN HLA-DR and CD69 membrane expression induced by autologous mono-lymphocytes and cell lines. 157
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 130
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 130
Induction and expansion of an anti-tumor immune response by B7-1+ tumor cells in dependence on the anatomical site of delivery and the dose applied 123
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 119
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 118
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes. 118
Hyperthermic treatment at 56 °C induces tumour-specific immune protection in a mouse model of prostate cancer in both prophylactic and therapeutic immunization regimens 116
Autologous cellular vaccine allows control of cancer immunoediting in a mouse model of plasmacytoma. 112
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 112
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 110
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 109
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 107
Analysis of CIITA encoding AIR-1 gene promoters in insulin-dependent diabetes mellitus and rheumatoid arthritis patients from the northeast of Italy: absence of sequence variability 104
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 104
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 102
Mitochondrial DNA polymorphism analyzed by restriction endonucleases in two sardinian populations 101
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 100
The Emerging Immunological Role of Post-Translational Modifications by Reactive Nitrogen Species in Cancer Microenvironment 99
Constitutive and inducible expression of HLA class II genes in normal cells is under the control of the AIR-1-encoded CIITa trans-activator 98
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 98
Induction of an antitumour adaptive immune response elicited by tumour cells expressing de novo B7-1 mainly depends on the anatomical site of their delivery: the dose applied regulates the expansion of the response 98
Structure and regulation of MHC system 97
Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. 97
Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. 96
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 95
HLA class II expression in uninducible hepatocarcinoma cells after transfection of AIR-1 gene product CIITA. Acquisition of antigen processing and presentation capacity. 94
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. 94
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 94
Effects of dietary wheat germ deprivation on the immune system in wistars rats: a pilot study 93
Evidence for a specific post-transcriptional mechanisms controlling the expression of HLA-DQ, but not -DR and -DP, molecules. 91
Divergent evolution in the mechanisms controlling MHC class II gene transcription in mouse and human. 91
A non-parametric method for the analysis of experimental tumour growth data 91
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 91
Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ beta-chain proteins: allelic polymorphism in splicing and polyadenylylation sites 90
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen. 90
The Endless Saga of Monocyte Diversity 89
Distinct regulation of HLA class II and class I cell surface expression in the THP-1 macrophage cell line after bacterial phagocytosis 87
A rapid and improved method for generating cDNA libraries in plasmid and phage vectors 87
Functional significance of polymorphism among MHC class II gene promoters. 86
SEQUENCE POLYMORPHISM OF HLA-DP b CHAINS 85
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 85
Identification of Ricin A chain HLA II-restricted epitopes by human T-cell clones. 84
Immune regulation by Mesenchymal Stem Cells derived from adult spleen and thymus. 83
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. 82
Interaction of human pancreatic ductal adenocarcinoma cells with polymeric scaffolds to develop tissue-engineered cancer models. 80
Staphylococcal enterotoxin-dependent lysis of MHC class II negative target cells by cytolytic T lymphocytes 79
Expression of HLA antigens in human pancreatic carcinomas 77
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 76
Transcriptional regulation of MHC class II genes 75
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 75
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of Major Histocompatibility Complex class II gene expression observed during differentiation from B cells to plasma cells. 74
CONSTITUTIVE AND INDUCIBLE EXPRESSION OF HLA CLASS II GENES IN NORMAL CELLS UNDER THE CONTROL OF THE AIR-1-ENCODED CIITA TRANS-ACTIVATOR 73
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle 73
Regulation of CD5 gene expression in interspecies human x mouse T cell hybrids 72
Polimorfismo genetico mitocondriale in popolazioni sarde esposte a differente pressione selettiva malarica 71
Mitochondrial DNA polymorphism in four Sardinian villages 71
Organization, polymorphism and regulation of class II genes of the major histocompatibility complex. 70
Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum 70
null 63
The Engagement Between MDSCs and Metastases: Partners in Crime 63
Oscillating growth patterns of multicellular tumour spheroids 62
HLA-DBQ1 typing of north east italian IDDM patients using amplified DNA oligonucleotide probes and a rapid DNA-enzyme immunoassay(DEIA). 62
A rapid and improved method for generating cDNA libraries in plasmid and phage lambda vectors 62
Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours. 60
MHC: AN INTEGRATED GENETIC SYSTEM WHICH ORCHESTRATES THE IMMUNE RESPONSE. 60
Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules 50
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones 49
HLA-DQB1 typing of north east Italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA) 45
null 33
Study of the optimal conditions for obtaining fusion complexes to be used as broad spectrum anti HIV-1 vaccine 33
MHC: orchestrating the immune response 31
Moonlighting Proteins Are Important Players in Cancer Immunology 23
"Open Sesame" to the complexity of pattern recognition receptors of myeloid-derived suppressor cells in cancer 21
A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment 13
Local ablation disrupts immune evasion in pancreatic cancer 11
Exploring the HLA complex in autoimmunity: from the risk haplotypes to the modulation of expression 7
Totale 7.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.110
article - articoli 18.368
book - libri 0
conference - conferenze 4.910
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 832
Totale 48.220
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020582 0 0 0 0 0 0 93 128 70 79 74 138
2020/2021818 76 106 63 77 86 101 13 58 47 12 121 58
2021/2022713 74 223 6 34 26 18 30 42 37 28 60 135
2022/20231.329 90 157 136 239 122 284 11 82 150 7 26 25
2023/2024649 14 42 47 102 64 110 30 50 2 40 98 50
2024/2025753 94 114 76 276 103 85 5 0 0 0 0 0
Totale 7.202